Inovio Pharmaceuticals: Q1 Earnings Insights


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Inovio Pharmaceuticals (NASDAQ:INO) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Earnings

Inovio Pharmaceuticals missed estimated earnings by 5.88%, reporting an EPS of $-0.36 versus an estimate of $-0.34.

Revenue was down $172.05 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.18 which was followed by a 5.86% drop in the share price the next day.

Here's a look at Inovio Pharmaceuticals's past performance:

QuarterQ4 2021Q3 2021Q2 2021Q1 2021
EPS Estimate-0.32-0.33-0.25-0.18
EPS Actual-0.50-0.29-0.39-0.27
Revenue Estimate2.84M970.00K1.21M850.00K
Revenue Actual839.00K291.70K272.82K371.12K

To track all earnings releases for Inovio Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: EarningsBZI-Recaps